First Trust NYSE Arca Biotechnology Index Fund (FBT) is an ETF managed by First Trust. Its largest position is Moderna, Inc. (MRNA), representing 5.26% of fund assets.
First Trust NYSE Arca Biotechnology Index Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FBT
- Type:
- ETF
- Manager:
- First Trust
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Moderna, Inc.
|
5.26% | $119,445,481.20 | 2,351,289 |
|
-
UNITED THERAPEUTICS Corp
|
4.36% | $98,938,120.02 | 166,849 |
|
-
Alkermes plc.
|
4.24% | $96,146,103.04 | 2,719,064 |
|
-
GILEAD SCIENCES, INC.
|
4.09% | $92,819,305.04 | 665,992 |
|
-
Axsome Therapeutics, Inc.
|
3.89% | $88,207,819.56 | 521,878 |
|
-
AMGEN INC
|
3.83% | $87,006,523.55 | 247,283 |
|
-
CORCEPT THERAPEUTICS INC
|
3.82% | $86,691,734.06 | 2,150,626 |
|
-
Krystal Biotech, Inc.
|
3.51% | $79,692,753.28 | 308,504 |
|
-
BIOGEN INC.
|
3.47% | $78,804,950.49 | 429,853 |
|
-
EXELIXIS, INC.
|
3.46% | $78,543,170.30 | 1,831,270 |
|
-
NEUROCRINE BIOSCIENCES INC
|
3.45% | $78,243,811.24 | 593,926 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
3.45% | $78,229,027.36 | 101,249 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
3.42% | $77,623,834.36 | 173,834 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
3.40% | $77,280,579.60 | 1,368,040 |
|
-
ARGENX SE
|
3.29% | $74,722,831.25 | 102,325 |
|
-
Sarepta Therapeutics, Inc.
|
3.24% | $73,643,325.44 | 3,384,344 |
|
-
HALOZYME THERAPEUTICS, INC.
|
3.17% | $71,923,043.09 | 1,112,843 |
|
-
BioNTech SE
|
3.16% | $71,789,353.68 | 807,711 |
|
-
INCYTE CORP
|
3.13% | $71,025,869.72 | 754,631 |
|
-
BeOne Medicines Ltd.
|
3.12% | $70,878,423.84 | 238,672 |
|
-
ILLUMINA, INC.
|
3.10% | $70,471,563.06 | 571,731 |
|
-
Natera, Inc.
|
3.03% | $68,836,158.02 | 344,198 |
|
-
ACADIA PHARMACEUTICALS INC
|
2.95% | $67,035,878.70 | 3,011,495 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.95% | $66,998,528.04 | 202,492 |
|
-
BIO-TECHNE Corp
|
2.83% | $64,153,069.50 | 1,227,575 |
|
-
GENMAB A/S
|
2.78% | $63,158,329.77 | 2,354,019 |
|
-
VERACYTE, INC.
|
2.72% | $61,789,763.61 | 1,918,341 |
|
-
REPLIGEN CORP
|
2.51% | $56,958,076.06 | 483,433 |
|
-
BRUKER CORP
|
2.36% | $53,490,938.76 | 1,480,923 |
|
-
NEOGENOMICS INC
|
2.00% | $45,471,822.76 | 6,128,278 |
|
-
DREYFUS GOVERNMENT CASH MANAGEMENT
|
0.06% | $1,413,994.11 | 1,413,994 |
|
-
DAIWA CAPITAL MARKETS AMERICA INC.
|
0.01% | $188,488.00 | 188,488 |
Advertisement (320x50)